Correction of hyperglycemia in type 1 diabetic models by transplantation of encapsulated insulin-producing cells derived from mouse embryo progenitor

Journal of Endocrinology

Volumn 208, Issue 3, 2011, Pages 245-255

  Shao, Shiying ^a,b   Gao, Yun ^b   Xie, Bing ^a,b   Xie, Fei ^b   Lim, Sai Kiang ^b,c   Li, GuoDong ^a,b  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c INSTITUTE OF MEDICAL BIOLOGY   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ALGINIC ACID; DEXTRAN; GLUCOSE; INSULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL DEATH; CELL ENCAPSULATION; CELL GROWTH; CELL MEMBRANE PERMEABILITY; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; EMBRYO; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; HYPOGLYCEMIA; IMMUNE SYSTEM; IMMUNOCOMPETENCE; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; MALE; MOUSE; MOUSE EMBRYO PROGENITOR DERIVED INSULIN PRODUCING 1 CELL; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; PERITONEAL CAVITY; PRIORITY JOURNAL; RELAPSE; STEM CELL; STEM CELL TRANSPLANTATION;

ALGINATES; ANIMALS; CAPSULES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; EMBRYONIC STEM CELLS; GLUCOSE TOLERANCE TEST; GLUCURONIC ACID; HEXURONIC ACIDS; HYPERGLYCEMIA; INSULIN; INSULIN-SECRETING CELLS; MALE; MICE; MICE, INBRED BALB C; TREATMENT OUTCOME;

EID: 79951776755     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1530/JOE-10-0378     Document Type: Article

References (42)

1. Abalovich AG, Bacque MC, Grana D & Milei J 2009 Pig pancreatic islet transplantation into spontaneously diabetic dogs. Transplantation Proceedings 41 328-330. (doi:10.1016/j.transproceed.2008.08.159)
2. Aguayo-Mazzucato C, Sanchez-Soto C, Godinez-Puig V, Gutierrez-Ospina G & Hiriart M 2006 Restructuring of pancreatic islets and insulin secretion in a postnatal critical window. PLoS ONE 1 e35. (doi:10.1371/journal.pone.0000035)
3. Asfari M, Janjic D, Meda P, Li G, Halban PA & Wollheim CB 1992 Establishment of 2-mercaptoethanol-dependent differentiated insulin-secreting cell lines. Endocrinology 130 167-178. (doi:10.1210/en.130.1.167)
4. Bonner-Weir S & Sharma A 2002 Pancreatic stem cells. Journal of Pathology 197 519-526. (doi:10.1002/path.1158)
5. Bonner-Weir S & Weir GC 2005 New sources of pancreatic β-cells. Nature Biotechnology 23 857-861. (doi:10.1038/nbt1115)
6. Calafiore R, Basta G, Luca G, Boselli C, Bufalari A, Giustozzi GM, Moggi L & Brunetti P 1997 Alginate/polyaminoacidic coherent microcapsules for pancreatic islet graft immunoisolation in diabetic recipients. Annals of the New York Academy of Sciences 831 313-322. (doi:10.1111/j.1749-6632.1997.tb52206.x)
7. Chen TS, Tan SS, Yeo WYR, Teh FJ, Luo R, Li GD & Luo R 2010 Delineating biological pathways unique to embryonic stem cell-derived insulin-producing cell lines from their non insulin-producing progenitor cell lines. Endocrinology 151 3600-3610. (doi:10.1210/en.2009-1418)
8. D'Amour KA, Bang AG, Eliazer S, Kelly OG, Agulnick AD, Smart NG, Moorman MA, Kroon E, Carpenter MK & Baetge EE 2006 Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nature Biotechnology 24 1392-1401. (doi:10.1038/nbt1259)
9. Efrat S 2002 Cell replacement therapy for type 1 diabetes. Trends in Molecular Medicine 8 334-339. (doi:10.1016/S1471-4914(02)02365-1)
10. Ferber S, Halkin A, Cohen H, Ber I, Einav Y, Goldberg I, Barshack I, Seijffers R, Kopolovic J, Kaiser N et al. 2000 Pancreatic and duodenal homeobox gene 1 induces expression of insulin genes in liver and ameliorates streptozotocin-induced hyperglycemia. Nature Medicine 6 568-572. (doi:10.1038/75050)
11. Fort A, Fort N, Ricordi C & Stabler CL 2008 Biohybrid devices and encapsulation technologies for engineering a bioartificial pancreas. Cell Transplantation 17 997-1003. (doi:10.3727/096368908786991498)
12. Fujikawa T, Oh SH, Pi L, Hatch HM, Shupe T & Petersen BE 2005 Teratoma formation leads to failure of treatment for type I diabetes using embryonic stem cell-derived insulin-producing cells. American Journal of Pathology 166 1781-1791. (doi:10.1016/S0002-9440(10)62488-1)
13. Gray DW 2001 An overview of the immune system with specific reference to membrane encapsulation and islet transplantation. Annals of the New York Academy of Sciences 944 226-239. (doi:10.1111/j.1749-6632.2001.tb03835.x)
14. de Groot M, Schuurs TA, Leuvenink HG & van Schilfgaarde R 2003 Macrophage overgrowth affects neighboring nonovergrown encapsulated islets. Journal of Surgical Research 115 235-241. (doi:10.1016/j.jss.2003.07.008)
15. de Groot M, Schuurs TA & van Schilfgaarde R 2004 Causes of limited survival of microencapsulated pancreatic islet grafts. Journal of Surgical Research 121 141-150. (doi:10.1016/j.jss.2004.02.018)
16. Halban PA 2004 Cellular sources of new pancreatic b cells and therapeutic implications for regenerative medicine. Nature Cell Biology 6 1021-1025. (doi:10.1038/ncb1104-1021)
17. Ianus A, Holz GG, Theise ND & Hussain MA 2003 In vivo derivation of glucose-competent pancreatic endocrine cells from bone marrow without evidence of cell fusion. Journal of Clinical Investigation 111 843-850. (doi:10.1172/JCI16502)
18. Ichii H & Ricordi C 2009 Current status of islet cell transplantation. Journal of Hepato-Biliary-Pancreatic Surgery 16 101-112. (doi:10.1007/s00534-008-0021-2)
19. Kataoka K, Han SI, Shioda S, Hirai M, Nishizawa M & Handa H 2002 MafA is a glucose-regulated and pancreatic β-cell-specific transcriptional activator for the insulin gene. Journal of Biological Chemistry 277 49903-49910. (doi:10.1074/jbc.M206796200)
20. Kizilel S, Garfinkel M & Opara E 2005 The bioartificial pancreas: progress and challenges. Diabetes Technology and Therapeutics 7 968-985. (doi:10.1089/dia.2005.7.968)
21. Kroon E, Martinson LA, Kadoya K, Bang AG, Kelly OG, Eliazer S, Young H, Richardson M, Smart NG, Cunningham J et al. 2008 Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Nature Biotechnology 26 443-452. (doi:10.1038/nbt1393)
22. Langlois G, Dusseault J, Bilodeau S, Tam SK, Magassouba D & Halle JP 2009 Direct effect of alginate purification on the survival of islets immobilized in alginate-based microcapsules. Acta Biomaterialia 5 3433-3440. (doi:10.1016/j.actbio.2009.05.029)
23. Li GD, Luo R, Zhang J, Yeo KS, Lian Q, Xie F, Tan EK, Caille D, Kon OL, Salto-Tellez M et al. 2009a Generating mESC-derived insulin-producing cell lines through an intermediate lineage-restricted progenitor line. Stem Cell Research 2 41-55. (doi:10.1016/j.scr.2008.07.006)
24. Li GD, Luo R, Zhang J, Yeo KS, Xie F, Way Tan EK, Caille D, Que J, Kon OL, Salto-Tellez M et al. 2009b Derivation of functional insulin-producing cell lines from primary mouse embryo culture. Stem Cell Research 2 29-40. (doi:10.1016/j.scr.2008.07.004)
25. Lim F & Sun AM 1980 Microencapsulated islets as bioartificial endocrine pancreas. Science 210 908-910. (doi:10.1126/science.6776628)
26. Mikos AG, Papadaki MG, Kouvroukoglou S, Ishaug SL & Thomson RC 1994 Mini-review: islet transplantation to create a bioartificial pancreas. Biotechnology and Bioengineering 43 673-677. (doi:10.1002/bit.260430717)
27. Murua A, Portero A, Orive G, Hernandez RM, de Castro M & Pedraz JL 2008 Cell microencapsulation technology: towards clinical application. Journal of Controlled Release 132 76-83. (doi:10.1016/j.jconrel.2008.08.010)
28. Omer A, Duvivier-Kali V, Fernandes J, Tchipashvili V, Colton CK & Weir GC 2005 Long-term normoglycemia in rats receiving transplants with encapsulated islets. Transplantation 79 52-58. (doi:10.1097/01.TP.0000149340. 37865.46)
29. Orive G, Hernandez RM, Gascon AR, Calafiore R, Chang TM, De Vos P, Hortelano G, Hunkeler D, Lacik I, Shapiro AM et al. 2003 Cell encapsulation: promise and progress. Nature Medicine 9 104-107. (doi:10.1038/nm0103-104)
30. Ricordi C & Edlund H 2008 Toward a renewable source of pancreatic β-cells. Nature Biotechnology 26 397-398. (doi:10.1038/nbt0408-397)
31. van Schilfgaarde R & de Vos P 1999 Factors influencing the properties and performance of microcapsules for immunoprotection of pancreatic islets. Journal of Molecular Medicine 77 199-205. (doi:10.1007/s001090050336)
32. Shapiro AM, Lakey JR, Ryan EA, Korbutt GS, Toth E, Warnock GL, Kneteman NM & Rajotte RV 2000 Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. New England Journal of Medicine 343 230-238. (doi:10.1056/NEJM200007273430401)
33. Shi Y, Hou L, Tang F, Jiang W, Wang P, Ding M & Deng H 2005 Inducing embryonic stem cells to differentiate into pancreatic β cells by a novel three-step approach with activin A and all-trans retinoic acid. Stem Cells 23 656-662. (doi:10.1634/stemcells.2004-0241)
34. Siebers U, Horcher A, Bretzel RG, Federlin K & Zekorn T 1997 Alginate-based microcapsules for immunoprotected islet transplantation. Annals of the New York Academy of Sciences 831 304-312. (doi:10.1111/j.1749-6632.1997. tb52205.x)
35. Siebers U, Horcher A, Brandhorst H, Brandhorst D, Hering B, Federlin K, Bretzel RG & Zekorn T 1999 Analysis of the cellular reaction towards microencapsulated xenogeneic islets after intraperitoneal transplantation. Journal of Molecular Medicine 77 215-218. (doi:10.1007/s001090050339)
36. Soria B, Roche E, Berna G, Leon-Quinto T, Reig JA & Martin F 2000 Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice. Diabetes 49 157-162. (doi:10.2337/ diabetes.49.2.157)
37. Soria B, Skoudy A & Martin F 2001 From stem cells to b cells: new strategies in cell therapy of diabetes mellitus. Diabetologia 44 407-415. (doi:10.1007/s001250051636)
38. Vaithilingam V, Sundaram G & Tuch BE 2008 Islet cell transplantation. Current Opinion in Organ Transplantation 13 633-638. (doi:10.1097/MOT. 0b013e328317a48b)
39. de Vos P, Hamel AF & Tatarkiewicz K 2002 Considerations for successful transplantation of encapsulated pancreatic islets. Diabetologia 45 159-173. (doi:10.1007/s00125-001-0729-x)
40. Weber C, Pohl S, Poertner R, Pino-Grace P, Freimark D, Wallrapp C, Geigle P & Czermak P 2010 Production process for stem cell based therapeutic implants: expansion of the production cell line and cultivation of encapsulated cells. Advances in Biochemical Engineering/Biotechnology 123 143-162. (doi:10.1007/10-2009-25)
41. Zimmermann H, Zimmermann D, Reuss R, Feilen PJ, Manz B, Katsen A, Weber M, Ihmig FR, Ehrhart F, Gessner P et al. 2005 Towards a medically approved technology for alginate-based microcapsules allowing long-term immunoisolated transplantation. Journal of Materials Science: Materials in Medicine 16 491-501. (doi:10.1007/s10856-005-0523-2)
42. Zimmermann H, Shirley SG & Zimmermann U 2007 Alginate-based encapsulation of cells: past, present, and future. Current Diabetes Reports 7 314-320. (doi:10.1007/s11892-007-0051-1)